SAROJA — Saroja Pharma Industries India Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Saroja Pharma Industries India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.65	3.64	3.22	3.32	3.39
Net Total Accounts Receivable
Net Total Receivables	142	112	163	266	173
Total Inventory
Total Other Current Assets
Total Current Assets	151	161	176	272	186
Net Property, Plant And Equipment	3.42	40	86.4	111	225
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	155	213	266	396	417
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	97.9	134	92.9	225	171
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	115	163	119	239	245
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	40.3	50.9	146	157	173
Total Liabilities & Shareholders' Equity	155	213	266	396	417
Total Common Shares Outstanding